Similar Search Results

Acquisitions of Start-ups by Incumbent Businesses A market selection process of “high-quality” entrants?

Andersson, Martin; Xiao, Jing - Centre for Innovation, Research and Competence in the … - 2014

We analyze the frequency and nature by which new firms are acquired by established businesses. Acquisitions are often considered to reflect a technology transfer process and to also constitute one way in which a “symbiosis” between new technology-based firms (NTBFs) and established...

Persistent link: https://www.econbiz.de/10010945043

Building absorptive capacity in less developed countries The case of Tanzania

Szogs, Astrid; Chaminade, Cristina; Azatyan, Ruzana - Centre for Innovation, Research and Competence in the … - 2008

African countries lag clearly behind developed countries when it comes to accumulating technological capabilities, upgrading and catching up. Also, firms in least developed countries are characterised by very low levels of absorptive capacity. It is therefore crucial to understand how this...

Persistent link: https://www.econbiz.de/10005077271

R&D and financial systems: the determinants of R&D expenditures in the Swedish pharmaceutical industry

Malmberg, Claes - Centre for Innovation, Research and Competence in the … - 2008

This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past...

Persistent link: https://www.econbiz.de/10005077278

Efficiency of Research and Innovation Systems for Economic Growth and Employment

Edquist, Charles - Centre for Innovation, Research and Competence in the … - 2014

The concept of a holistic innovation policy is defined in this paper, and it is discussed what it is, why it is … relevant and how it can be implemented. One of the main conclusions is that the innovation policies in European countries are … still linear (and not holistic), in spite of the fact that the linear view has been completely abandoned by innovation …

Persistent link: https://www.econbiz.de/10010778810

Multiple Paths of Development: Knowledge Bases and Institutional Characteristics of the Swedish Food Sector

Zukauskaite, Elena; Moodysson, Jerker - Centre for Innovation, Research and Competence in the … - 2013

, focusing on the relation between institutions and innovation practices and taking into account the diversity of actors …

Persistent link: https://www.econbiz.de/10010818687

Building absorptive capacity in less developed countries The case of Tanzania

Szogs, Astrid; Chaminade, Cristina; Azatyan, Ruzana - Centre for Innovation, Research and Competence in the … - 2008

Persistent link: https://www.econbiz.de/10008764061

R&D and financial systems: the determinants of R&Dexpenditures in the Swedish pharmaceutical industry

Malmberg, Claes - Centre for Innovation, Research and Competence in the … - 2008

Persistent link: https://www.econbiz.de/10008764489

Innovation in peripheral regions: Do collaborations compensate for a lack of local knowledge spillovers?

Grillitsch, Markus; Nilsson, Magnus - Centre for Innovation, Research and Competence in the … - 2014

It is widely accepted that firms in peripheral regions benefit to a lesser extent from local knowledge spillovers than firms located in agglomerations or industrial clusters. This paper investigates the extent to which innovative firms in peripheral regions compensate for the lack of access to...

Persistent link: https://www.econbiz.de/10011105519

The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data

Lichtenberg, Frank; Pettersson, Billie - CESifo - 2012

We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …

Persistent link: https://www.econbiz.de/10010569681